The diagnosis of myelodysplastic syndromes (MDS) and related disorders such as chronic
myelomonocytic leukemia (CMML) has historically relied on combining clinical information …

Flow cytometry (FC) is recognized as one of the important tools in the diagnosis of
myelodysplastic syndromes (MDS), especially when cytomorphology and cytogenetics are …

Findings of recent studies indicate that flow cytometry (FCM) may be valuable in the
diagnosis and prognostication of myelodysplastic syndromes (MDS). This approach appears …

Abstract 595 Diagnosis and classification of myelodysplastic syndromes (MDS) is based on
cytomorpholgy (CM) and cytogenetics (CG). By the identification of MDS-related aberrant …

Introduction: The myelodysplastic syndrome (MDS) is a monoclonal stem cell disease which
may cause peripheral cytopenias such as anaemia, thrombocytopenia and neutropenia …

Introduction Assessment of myelodysplasia (MDS) by flow cytometry (FCM) includes
elaborate panels, and interpretation is observer-dependent. This study evaluates single tube …

Maturation and differentiation of hematopoietic cells is a tightly controlled process, leading to
highly conserved levels of antigen expression at different stages of development. In …

Introduction: Myelodysplastic syndromes (MDSs) are a group of disorders characterised by
ineffective haematopoiesis, leading to dysplasia in one, two or all three cell lineages …

Background: Myelodysplastic syndromes (MDSs) are a heterogeneous group of bone
marrow disorders. Morphology may be difficult to evaluate in some patients, either due to …

Background: Myelodysplastic syndromes (MDS) are a class of myeloid neoplasms featuring
inefficient maturation and differentiation of hematopoietic cells, blood cytopenia, and a high …